Effects of daidzein sulfates on blood pressure and artery of rats

Basic and Clinical Pharmacology and Toxicology

Volumn 99, Issue 6, 2006, Pages 425-430

  Cao, Yong Xiao ^a   Yang, Xiao Jiang ^a   Liu, Jing ^a   Li, Ke Xi ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; DAIDZEIN; DAIDZEN SULFATE; NORADRENALIN; PHYTOESTROGEN; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; HYPOTENSION; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; TRADITIONAL MEDICINE; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; BLOOD PRESSURE; CALCIUM; CALCIUM CHLORIDE; HYPERTENSION; ISOFLAVONES; MALE; MESENTERIC ARTERIES; NOREPINEPHRINE; PHYTOESTROGENS; POTASSIUM CHLORIDE; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; SEROTONIN; SULFURIC ACID ESTERS; VASODILATOR AGENTS;

EID: 33751364461     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_565.x     Document Type: Article

References (24)

1. Adner, M., L. Cantera, F. Ehlert, L. Nilsson & L. Edvinsson: Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Brit. J. Pharmacol. 1996, 119, 1159-1166.
2. Anderson, J. W., B. M. Johnstone & M. E. Cooknewell: Meta-analysis of the effects of soy protein intake on serum lipids. New Engl. J. Med. 1995, 333, 276-282.
3. Anthony, M. S.: Phytoestrogens and cardiovascular disease: where's the meat? Arterioscler. Thromb. Vasc. Bio. 2002, 22, 1245-1247.
4. Broekaert, A. & T. Godfraiend: A comparison of the inhibitery effect of cinnarizine and papaverineon the noradrenaline and calcium evoked contraction of isolated rabbit aorta and mesenteric arteries. Eur. J. Pharmacol. 1979, 53, 281-228.
5. Cao, Y. X., L. C. He, C. B. Xu & L. Edvinsson: Alteration in contractile response to noradrenaline, 5-hydroxytryptamine, sarafotoxin 6c, and angiotensin II in rat mesenteric artery during organ culture. Acad. J. X. J. U. 2004, 16, 155-159.
6. 2+-release. Arch. Pharm. Res. 2005, 28, 710-715.
7. Fairley, B., N. P. Botting & A. Cassidy: The synthesis of daidzein sulfates. Tetrahedron 2003, 59, 5407-5410.
8. (2C) receptor activation. Eur. J. Pharmacol. 2000, 401, 221-227.
9. He, J. T., Zh. H. Shi, J. Yan, M. P. Zhao, Zh. Q. Guo & W. B. Chang: Biotin-avidin amplified enzyme-linked immunosorbent assay for determination of isoflavone daidzein. Talanta 2005, 65, 621-626.
10. Liu, Q. G., Z. T. Zhang & D. Xu: Synthesis, crystal structure and activity of daidzein sulfates. Chem. J. Chin. Uni. 2003, 24, 820-825.
11. Messina, M. & S. Barnes: The role of soy products in reducing risk of cancer. J. Natl. Cancer. Inst. 1991, 83, 541-546.
12. Mishra, S. K., S. E. Abbot, Z. Choudhury, M. Cheng, N. Khatab, N. J. Maycock, A. Zavery & P. I. Aaronson: Endothelium-dependent relaxation of rat aorta and main pulmonary artery by the phytoestrogens genistein and daidzein. Cardiovasc. Res. 2000, 46, 539-546.
13. Nestel, P. J., S. Pomeroy, S. Kay, P. Komesaroff, J. Behrsing, J. D. Cameron & L. West: Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J. Clin. Endocrinol. Metab. 1999, 84, 895-898.
14. Nevala, R., R. Korpela & H. Vapaatalo: Plant derived estrogens relax rat mesenteric artery in vitro. Life Sci. 1998, 65, 95-100.
15. Räthel, T. R., J. F. Leikert, A. M. Vollmar & V. M. Dirsch: The soy isoflavone genistein induces a late but sustained activation of the endothelial nitric oxide-synthase system in vitro. Brit. J. Pharmacol. 2005, 144, 394-399.
16. Scheiber, M. D., J. H. Liu, M. T. Subbiah, R. W. Rebar & K. D. Setchell: Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause 2001, 8, 384-392.
17. Soidinsalo, O. & K. Wähälä: Synthesis of phytoestrogenic isoflavonoid disulfates. Steroids 2004, 69, 613-616.
18. Stark, A. & Z. Madar: Phytoestrogens: a review of recent findings. J. Pediatr. Endocrinol. Metab. 2002, 15, 561-572.
19. Totta, P., F. Acconcia, F. Virgili, A. Cassidy, P. D. Weinberg, G. Rimbach & M. Marino: Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-beta in cultured human cancer cells. J. Nutr. 2005, 135, 2687-2693.
20. Wong, C. K & W. M. Keung: Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase. Biochem. Biophys. Res. Commun. 1997, 233, 579-583.
21. Woodman, O. L., M. A. Missen & M. Boujaoude: Daidzein and 17 beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1. J. Cardiovasc. Pharmacol. 2004, 44, 155-163.
22. Zeng, J., Zh. Y. Zeng, Zh. H. Huang, F. Qiu & H. Y. Ye: Antihypoxia effect of 3′-daidzein sulfonate sodium. China J. Chin. Rehabilitation 2005, 10, 130-132.
23. Zhang, Z. T., Q. Y. Wang, Y. He, X. B. Wang, D. Xue & J. B. Zheng: Syntheses, crystal structures and biological activity of bimethylation daidzein sulfonates. Chem. J. Chin. Uni. 2005, 26, 2247-2253.
24. Zhu, L. H. & L. C. He: Qual itative and quantitative analysis of the effective part and effective components of Radix Puerariae. J. Xian Jiaotong University (Med. Sci.) 2005, 26, 216-219.